LEKKO Mikoderil cream for external use 1% tube 30 g No. 1
Category
Antifungal
Scope of the medicinal product
Dermatology
Release form
Cream
Manufacturer country
Russia
Package quantity, pcs
one
Release form
Cream for external use 1% white, homogeneous, with a weak specific odor.
pharmachologic effect
Naftifine - active ingredient
Mikoderila is an antifungal agent belonging to the allylamine class. The mechanism of its action is due to the ability to inhibit squalene-2,3-epoxidase, as a result of which the formation of ergosterol, which is part of the cell wall of the fungus, decreases. Naftifine affects squalene epoxidase and does not affect the cytochrome P450 system. The drug is active against molds (Aspergillus), dermatophytes (Microsporum, Epidermophyton, Trichophyton), yeast and yeast-like fungi (Candida spp., Pityrosporum), as well as some other types of fungi (for example, Sporothrix schenckii). On dermatophytes and molds, naftifine has a fungicidal effect, on yeast fungi, depending on the strain of the microorganism, it has a fungicidal or fungistatic effect.Has antibacterial activity against gram-negative and gram-positive microorganisms that cause the development of secondary bacterial infections. Due to its anti-inflammatory properties, the drug contributes to the rapid disappearance of symptoms of inflammation, especially itching.
Indications
- fungal infections of smooth skin and skin folds (tinea corporis, tinea inquinalis)
- interdigital mycoses (tinea manum, tinea pedum)
- fungal infections of the nails (onychomycosis)
- candidiasis of the skin
- pityriasis versicolor
- dermatomycosis (with or without itching).
Contraindications
- hypersensitivity to naftifine, benzyl alcohol or other components of the drug
- pregnancy and lactation (the safety and efficacy of the drug in this category of patients has not been studied).
With caution: childhood (clinical experience is limited).
Application during pregnancy and lactation
The safety profile of naftifine when used during pregnancy and lactation has not been studied, therefore Mikoderil is contraindicated in women during these periods of life.
special instructions
According to the instructions, Micoderil is not intended for use in ophthalmology.
Treatment with the drug is carried out in courses.
Care should be taken when applying the ointment / solution to avoid contact with open wounds.
Structure
1 g of cream: active substance: naftifine hydrochloride - 10 mg
additional components: isopropyl myristate - 80 mg, cetostearyl alcohol - 80 mg, polysorbate 60 - 61 mg, cetyl palmitate - 20 mg, sorbitan stearate - 19 mg, benzyl alcohol - 10 mg, sodium hydroxide - 1.2 mg, purified water - up to 1000 mg.
Method of administration and dosage
Outwardly.
In case of skin lesions, Mikoderil is applied 1 time / day to the affected skin surface and adjacent areas, after thorough cleaning and drying (capturing approximately 1 cm of a healthy skin area along the edges of the affected area).
The duration of therapy for dermatomycosis is 2-4 weeks (if necessary - up to 8 weeks), with candidiasis - 4 weeks.
In case of nail damage, Mikoderil is applied 2 times / day to the affected nail.
Before the first use of the drug, the affected part of the nail is removed as much as possible with scissors or a nail file.
The duration of therapy for opychomycosis is up to 6 months.
To prevent relapse, treatment should be continued for at least 2 weeks after the disappearance of clinical symptoms.
Side effects
There may be reactions at the site of application: dry skin, skin flushing and burning.
Side effects are reversible and do not require treatment withdrawal.
If any of the side effects indicated in the instructions are aggravated, or any other side effects not indicated in the instructions are noted, you should immediately inform your doctor about it.
Drug interactions
The interaction of Mikoderil with its simultaneous use with other drugs has not been noted.
Storage conditions
Temperature no more than 25 ° С.
Shelf life 2 years
Active substance
Naftifin
Name ENG
MYCODERIL
Clinical and pharmacological group
Antifungal drug for external use
ATX code
Naftifine
Dosage
1% x 30g
Structure
1 g of cream: active substance: naftifine hydrochloride - 10 mg
additional components: isopropyl myristate - 80 mg, cetostearyl alcohol - 80 mg, polysorbate 60 - 61 mg, cetyl palmitate - 20 mg, sorbitan stearate - 19 mg, benzyl alcohol - 10 mg, sodium hydroxide - 1.2 mg, purified water - up to 1000 mg.
Indications
fungal infections of smooth skin and skin folds (tinea corporis, tinea inquinalis)
interdigital mycoses (tinea manum, tinea pedum)
fungal infections of the nails (onychomycosis)
candidiasis of the skin
pityriasis versicolor
dermatomycosis (with or without itching)
Storage conditions and periods
Store at a temperature not exceeding 25 ° C.
Shelf life 2 years.
INN / Active ingredient
Naftifin
Contraindications
hypersensitivity to naftifine, benzyl alcohol or other components of the drug
pregnancy and lactation (the safety and efficacy of the drug in this category of patients has not been studied).
With caution: childhood (clinical experience is limited).
Specifications
Category
Antifungal
Scope of the medicinal product
Dermatology
Release form
Cream
Manufacturer country
Russia
Package quantity, pcs
one
Scope of application
Dermatology
Way of introduction
Locally
,
Outwardly
Vacation conditions
Without recipe
Brand name
OTCPharm
The amount of the dosage form in the primary package
30 g
Primary packaging type
Tuba
Type of consumer packaging
Pack of cardboard
Dosage form
Cream for external use
Packaging
Cardboard box
Dosage (volume) of the substance in the preparation
naftifine hydrochloride - 10.0 mg
The target audience
Adult
Expiration date in days
730
Package weight, g
45
Mode of application
:
Outwardly. < br> With skin lesions, Mikoderil is applied 1 time / day to the affected skin surface and adjacent areas, after thorough cleaning and drying (capturing approximately 1 cm of healthy skin along the edges of the affected area). < br> Duration of therapy for dermatomycosis - 2-4 weeks (if necessary - up to 8 weeks), with candidiasis - 4 weeks. < br> In case of nail damage, Micoderil is applied 2 times / day to the affected nail.
Before the first use of the drug, the affected part of the nail is removed as much as possible with scissors or a nail file. < br> Duration of therapy for opychomycosis is up to 6 months. < br> To prevent relapse, treatment should be continued for at least 2 weeks after the disappearance of clinical symptoms. < br>
Information on technical characteristics, delivery set, country of manufacture